Paediatric Hematologic Research Group
1 – 122 of 122
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Dilemmas on emicizumab in children with haemophilia A : A survey of strategies from PedNet centres
(
- Contribution to journal › Article
- 2017
-
Mark
Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
Endovascular treatment of vein of Galen aneurysmal malformation using rapid ventricular pacing : A case report
(
- Contribution to journal › Article
-
Mark
Cerebellar mutism syndrome in children with brain tumours of the posterior fossa
(
- Contribution to journal › Article
-
Mark
Ataxia-pancytopenia syndrome with SAMD9L mutations
(
- Contribution to journal › Article
- 2016
-
Mark
BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.
(
- Contribution to journal › Article
-
Mark
Origin of mutation in sporadic cases of severe haemophilia A in Sweden.
(
- Contribution to journal › Article
-
Mark
Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
(
- Contribution to journal › Article
-
Mark
Breath-holding spells occur disproportionately more often in children with transient erythroblastopenia
(
- Contribution to journal › Article
- 2015
-
Mark
Haemophilia in Sweden – Studies on mutations and clinical implications
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The current status of prophylactic replacement therapy in children and adults with haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology
(
- Contribution to journal › Article
-
Mark
Switching treatments in haemophilia: is there a risk of inhibitor development?
(
- Contribution to journal › Scientific review
-
Mark
Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.
2015) In Haemophilia(
- Contribution to journal › Article
- 2014
-
Mark
Prenatal diagnosis of haemophilia in Sweden now more commonly used for psychological preparation than termination of pregnancy.
(
- Contribution to journal › Article
-
Mark
Factor VIII therapy for hemophilia A: current and future issues
(
- Contribution to journal › Scientific review
-
Mark
Perinatal aspects of haemophilia
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Origin of Swedish hemophilia B mutations
(
- Contribution to journal › Article
-
Mark
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
(
- Contribution to journal › Article
-
Mark
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
(
- Contribution to journal › Article
-
Mark
Plastic surgical treatment of purpura fulminans: Long-term follow-up of two patients.
(
- Contribution to journal › Article
- 2012
-
Mark
Lupus anticoagulants in two children-bleeding due to nonphospholipid-dependent antiprothrombin antibodies.
(
- Contribution to journal › Article
-
Mark
Haemophilia Care in Europe: the ESCHQoL study
(
- Contribution to journal › Article
-
Mark
Origin of Swedish hemophilia A mutations
(
- Contribution to journal › Article
-
Mark
Investigation of disease-associated factors in haemophilia A patients without detectable mutations.
(
- Contribution to journal › Article
-
Mark
How to manage invasive procedures in children with haemophilia.
(
- Contribution to journal › Article
-
Mark
Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.
(
- Contribution to journal › Article
-
Mark
New treatments in hemophilia: insights for the clinician.
(
- Contribution to journal › Article
- 2011
-
Mark
Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?
(
- Contribution to journal › Article
-
Mark
The need for speed in the management of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
(
- Contribution to journal › Article
-
Mark
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
(
- Contribution to journal › Article
-
Mark
Delivery of a severe haemophilia foetus - vaginal delivery
(
- Contribution to journal › Published meeting abstract
-
Mark
Ovanliga ärftliga former av blödarsjuka. Blödningssymtom, familjehistoria och laboratorieanalyser ger diagnosen.
(
- Contribution to journal › Article
-
Mark
Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden
2011) XXIII Congress of the International Society on Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 9. p.462-462(
- Contribution to journal › Published meeting abstract
-
Mark
Joint protection in haemophilia
(
- Contribution to journal › Article
- 2010
-
Mark
European Initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
(
- Contribution to journal › Published meeting abstract
-
Mark
Why is the frequency of inhibitors increasing among Swedish children with severe hemophilia A?
(
- Contribution to journal › Published meeting abstract
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
(
- Contribution to journal › Scientific review
-
Mark
Hemophilia A patients without detectable mutations - investigation of disease-associated factors
(
- Contribution to journal › Published meeting abstract
-
Mark
Management of bleedings in carriers
(
- Contribution to journal › Published meeting abstract
-
Mark
Quality of life in parents of children with haemophilia - results of the ESCHQoL study
(
- Contribution to journal › Published meeting abstract
-
Mark
European initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
(
- Contribution to journal › Published meeting abstract
-
Mark
The Fourth Annual Meeting of the International Network for Pediatric Hemophilia: Current Challenges and Recommendations in the Clinical Care of Children with Hemophilia.
(
- Contribution to journal › Article
-
Mark
Anti-prothrombin antibodies are associated with thrombosis in children.
(
- Contribution to journal › Article
-
Mark
The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery.
(
- Contribution to journal › Article
-
Mark
Venös tromboembolism hos barn
2010) p.161-174(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2009
-
Mark
Prophylactic therapy in haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
(
- Contribution to journal › Scientific review
-
Mark
Successful thrombolysis of neonatal bilateral renal vein thrombosis originating in the IVC.
(
- Contribution to journal › Article
-
Mark
Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
(
- Contribution to journal › Article
-
Mark
Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer.
2009) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18. p.2501-2506(
- Contribution to journal › Article
-
Mark
An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
(
- Contribution to journal › Article
- 2008
-
Mark
Venous access - why such diverse experiences of central venous lines?
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.96-96(
- Contribution to journal › Published meeting abstract
-
Mark
Management of delivery and neonatal period
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.5-5(
- Contribution to journal › Published meeting abstract
-
Mark
Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG)
(
- Contribution to journal › Article
-
Mark
Quality of life in haemophilia carriers - preliminary results of the ESCHQoL study
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.150-150(
- Contribution to journal › Published meeting abstract
-
Mark
Management of carriers and babies with haemophilia
(
- Contribution to journal › Article
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
Female haemophilia A caused by skewed X inactivation
(
- Contribution to journal › Letter
-
Mark
Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
(
- Contribution to journal › Article
-
Mark
Being a carrier of haemophilia - how does it influence quality of life?
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.152-153(
- Contribution to journal › Published meeting abstract
-
Mark
Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?
(
- Contribution to journal › Article
- 2007
-
Mark
The risk associated with indwelling catheters in children with haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Prevention of bleeding in haemophilia: trends, overcoming barriers and future treatment options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study
(
- Contribution to journal › Article
-
Mark
The thalassaemia syndromes
(
- Contribution to journal › Scientific review
-
Mark
Gadolinium Contrast Agent is of Limited Value for Magnetic Resonance Imaging Assessment of Synovial Hypertrophy in Hemophiliacs.
(
- Contribution to journal › Article
- 2006
-
Mark
Studies of chronic ITP in children and adolescents.
(
- Contribution to journal › Article
-
Mark
Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL)
(
- Contribution to journal › Article
-
Mark
Are randomized clinical trials the only truth? Not always
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Functional Analysis of the Factor IX Epidermal Growth Factor-Like Domain Mutation Ile66Thr Associated with Mild Hemophilia B.
(
- Contribution to journal › Article
-
Mark
Talassemi i Sverige – Behandlingsmål och uppföljning varierar kraftigt.
(
- Contribution to journal › Article
- 2005
-
Mark
Changing pattern of care of boys with haemophilia in western European centres
(
- Contribution to journal › Article
-
Mark
MRI scores of ankle joints in children with haemophilia--comparison with clinical data.
(
- Contribution to journal › Article
-
Mark
Compatible scales for progressive and additive MRI assessments of haemophilic arthropathy.
(
- Contribution to journal › Article
-
Mark
Akut hematologi i nyföddhetsperioden
2005)(
- Book/Report › Book
-
Mark
Risk factors for venous thrombosis in Swedish children and adolescents.
(
- Contribution to journal › Article
-
Mark
Childhood idiopathic thrombocytopenic purpura in the Nordic countries: Epidemiology and predictors of chronic disease
(
- Contribution to journal › Article
-
Mark
Blödningssjukdomar och tromboser
2005)(
- Book/Report › Book
- 2004
-
Mark
Central venous catheters in children with haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Optimizing factor prophylaxis for the haemophilia population: where do we stand?
(
- Contribution to journal › Article
-
Mark
Untitled - Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A new magnetic resonance imaging scoring method for assessment of haemophilic arthropathy.
(
- Contribution to journal › Article
-
Mark
Care of the child with haemophilia.
2004)(
- Book/Report › Book
- 2003
-
Mark
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
(
- Contribution to journal › Letter
-
Mark
Third and Fourth Workshops of the European paediatric network for haemophilia management.
(
- Contribution to journal › Article
-
Mark
Central venous lines in haemophilia.
(
- Contribution to journal › Article
-
Mark
Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B.
(
- Contribution to journal › Article
-
Mark
Genetic counselling of haemophilia carriers
(
- Contribution to journal › Article
-
Mark
HEMOPHILIA A AND B WITH SPECIAL REFERENCE TO INHIBITOR DEVELOPMENT AND EXPERIMENTAL STUDIES OF FACTORS VIII AND IX
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Paediatric care of the child with haemophilia.
(
- Contribution to journal › Article
-
Mark
Breastfeeding does not influence the development of inhibitors in haemophilia.
(
- Contribution to journal › Article
-
Mark
The N-terminal EGF domain of coagulation factor IX: Probing its functions in the activation of factor IX and factor X with a monoclonal antibody.
(
- Contribution to journal › Article
-
Mark
Aspects of haemophilia prophylaxis in Sweden.
(
- Contribution to journal › Article
-
Mark
Venous access in children with inhibitors.
2002) p.36-36(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2001
-
Mark
Optimal treatments for patients with bleeding disorders.
(
- Contribution to journal › Letter
-
Mark
Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity
(
- Contribution to journal › Article
-
Mark
An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX
(
- Contribution to journal › Article
-
Mark
Broad spectrum of time of detection, primary symptoms and disease progression in infants with HIV-1 infection
(
- Contribution to journal › Article
- 2000
-
Mark
Factor VIII inhibitors in two families with mild haemophilia A: structural analysis of the mutations
(
- Contribution to journal › Article
-
Mark
The Malmo model for immune tolerance induction: impact of previous treatment on outcome
(
- Contribution to journal › Article
- 1999
-
Mark
Haemophilia B carrier detection by factor IX:C analysis; no impact of the type of mutation or severity of disorder
(
- Contribution to journal › Article
-
Mark
Centraliserad vård grundläggande i vårdprogram för blödarsjuka
(
- Contribution to journal › Article
-
Mark
Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling
(
- Contribution to journal › Article
-
Mark
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized
(
- Contribution to journal › Article
-
Mark
Prenatal Diagnosis of Haemophilia - psychological, social and ethical aspects
1999)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Origin of mutation in sporadic cases of haemophilia A
(
- Contribution to journal › Article
-
Mark
Reproductive choices of haemophilia carriers
(
- Contribution to journal › Article
- 1997
-
Mark
Identifying carriers at high risk for negative reactions when performing prenatal diagnosis of haemophilia
(
- Contribution to journal › Article
- 1996
-
Mark
Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 1995
-
Mark
Inversions of the factor VIII gene in Swedish patients with severe haemophilia A
(
- Contribution to journal › Article
-
Mark
The impact of prenatal diagnosis on the incidence of haemophilia in Sweden
(
- Contribution to journal › Article
- 1992
-
Mark
Antenatal diagnosis of haemophilia B by amplification and electrophoresis of an exon fragment with a short deletion
(
- Contribution to journal › Article
-
Mark
Further characterization of the new marker at DXS115 with regard to carrier detection in hemophilia A
(
- Contribution to journal › Letter
-
Mark
Origin of mutation in sporadic cases of haemophilia-B
(
- Contribution to journal › Article
- 1991
-
Mark
Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosome
(
- Contribution to journal › Article
-
Mark
More than half the sporadic cases of Hemophilia A in Sweden are due to a recent mutation
(
- Contribution to journal › Article
- 1990
-
Mark
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate
(
- Contribution to journal › Letter
- 1989
-
Mark
How do carriers of hemophilia experience prenatal diagnosis (PND)? : Carriers' Immediate and later reactions to amniocentesis and fetal blood sampling
(
- Contribution to journal › Article
- 1987
-
Mark
How do carriers of hemophilia experience prenatal diagnosis by fetal blood sampling?
(
- Contribution to journal › Article